Clinical Characteristics of the West Nile Fever Outbreak, Israel, 2000
Michal Y. Chowers*
, Ruth Lang*, Faris Nassar†, Debora Ben-David‡, Michael Giladi§, Eitan Rubinshtein‡, Avi Itzhaki¶, Josef Mishal#, Yardena Siegman-Igra§, Ruth Kitzes**, Neora Pick††, Zvi Landau‡‡, Dana Wolf§§, Hanna Bin¶¶, Ella Mendelson¶¶, Silvio D. Pitlik##, and Miriam Weinberger##
Author affiliations: *Meir Medical Center, Kfar Sava, Israel; †Western Galilee Hospital, Nahariya, Israel; ‡Chaim Sheba Medical Center, Tel Hashomer, Israel; §Tel Aviv Sourasky Medical Center, Tel-Aviv, Israel; ¶Assaf Harofeh Medical Center, Zrifin, Israel; #Barzilai Medical Center, Ashkelon, Israel; **Carmel Medical Center, Haifa, Israel; ††Bnei-Zion Medical Center, Haifa, Israel; ‡‡Kaplan Medical Center, Rehovot, Israel; §§Hadassah Medical Center, Jerusalem, Israel; ¶¶Public Health Services, Ministry of Health, Tel Hashomer, Israel; ##Rabin Medical Center, Belinson Campus, Petach Tikva, Israel
Main Article
Figure 2
Figure 2. . Number of positive blood samples for immunoglobulin (Ig) M serology and time from beginning of symptoms. Blood samples were obtained from the patients upon initial suspicion of the diagnosis of West Nile fever. Bars represent the numbers of persons with positive serology at a given time after the onset of symptoms.
Main Article
Page created: April 27, 2012
Page updated: April 27, 2012
Page reviewed: April 27, 2012
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.